Calixar raises $1.1 mln

Calixar has completed a 1 million Euro (US$1.1 million) round of financing with its historical investors - Siparex, Veymont Participations, INPG Entreprise SA - and regional business angels, Health-Angels Rhône-Alpes, Savoie Angels and Grenoble Angels. Bpifrance, the French public investment bank, and the Banque Populaire supplemented this funding through repayable advance and specific credit supported by the European Union, Calixar said. Lyon, France-based Calixar is a biotech company that specializes in the native isolation of complex therapeutic targets and antigens.

North AmericaUSBriefs